跳至主要内容
临床试验/DRKS00020813
DRKS00020813已完成不适用

Cerebral oxygen saturation as an indicator of postoperative cardio-renal organ function and neurocognitive outcome in patients undergoing transcatheter aortic valve implantation.

Immanuel Klinikum Bernau, Herzzentrum Brandenburg0 个研究点目标入组 146 人开始时间: 2022年12月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
146

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Elective transcatheter aortic valve implantation (TAVI).
  • No contraindication to neurocognitive testing
  • Ability to understand the scope and significance of the study
  • Written informed consent to participate in the study

排除标准

  • Emergency intervention
  • Dialysis patients
  • Patient (or proxy) is unable to provide written informed consent to participate in the
  • give written informed consent for participation in the study
  • Diseases, due to which neurocognitive testing is not possible
  • Attending physician does not recommend participation in the study

研究者

发起方
Immanuel Klinikum Bernau, Herzzentrum Brandenburg

相似试验

Cerebral oxygen saturation as an indicator of... | 临床试验